“…The introduction of a,a-dialkyl-a-amino acids into peptide sequences results in significant restriction of the available range of backbone conformations [1,2]. Several achiral C~,C~-dialkyl glycines (H2N-CRIR2-COOH) with linear substitutents (like a-aminoisobutyric acid (Aib), diethylglycine (Deg), dipropylglycine (Dpg), dibutylglycine (Dbg)), cyclic substitutents (like Acnc'S where 'n' is the number of carbon atoms in the cycloalkane ring; 1-aminocyclopentane-l-carboxylic acid (Acsc), 1-aminocyclo-hexane-l-carboxylic acid (Ac6c), 1aminocycloheptane-l-carboxylic acid (Ac7c)) and aromatic substitutents (like diphenylglycine, dibenzylglycine) have been synthesized [4]. Several achiral C~,C~-dialkyl glycines (H2N-CRIR2-COOH) with linear substitutents (like a-aminoisobutyric acid (Aib), diethylglycine (Deg), dipropylglycine (Dpg), dibutylglycine (Dbg)), cyclic substitutents (like Acnc'S where 'n' is the number of carbon atoms in the cycloalkane ring; 1-aminocyclopentane-l-carboxylic acid (Acsc), 1-aminocyclo-hexane-l-carboxylic acid (Ac6c), 1aminocycloheptane-l-carboxylic acid (Ac7c)) and aromatic substitutents (like diphenylglycine, dibenzylglycine) have been synthesized [4].…”